NDC 23594-505
MILLIPRED
Prednisolone
MILLIPRED is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cerecor, Inc.. The primary component is Prednisolone.
| Product ID | 23594-505_09fee8bc-6178-4b42-bfa8-c0dc38dd245a |
| NDC | 23594-505 |
| Product Type | Human Prescription Drug |
| Proprietary Name | MILLIPRED |
| Generic Name | Prednisolone |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-03-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA080354 |
| Labeler Name | Cerecor, Inc. |
| Substance Name | PREDNISOLONE |
| Active Ingredient Strength | 5 mg/1 |
| Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
Packaging
NDC 23594-505-01
100 TABLET in 1 BOTTLE (23594-505-01)
| Marketing Start Date | 2014-03-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 23594-505-02 [23594050502]
MILLIPRED TABLET
| Marketing Category | ANDA |
| Application Number | ANDA080354 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-11-16 |
| Marketing End Date | 2020-06-30 |
NDC 23594-505-21 [23594050521]
MILLIPRED TABLET
| Marketing Category | ANDA |
| Application Number | ANDA080354 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-03-01 |
| Marketing End Date | 2020-06-30 |
NDC 23594-505-48 [23594050548]
MILLIPRED TABLET
| Marketing Category | ANDA |
| Application Number | ANDA080354 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-03-01 |
| Marketing End Date | 2020-06-30 |
NDC 23594-505-01 [23594050501]
MILLIPRED TABLET
| Marketing Category | ANDA |
| Application Number | ANDA080354 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-03-01 |
NDC 23594-505-50 [23594050550]
MILLIPRED TABLET
| Marketing Category | ANDA |
| Application Number | ANDA080354 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-01-21 |
| Marketing End Date | 2020-06-30 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| PREDNISOLONE | 5 mg/1 |
Pharmacological Class
- Corticosteroid [EPC]
- Corticosteroid Hormone Receptor Agonists [MoA]
NDC Crossover Matching brand name "MILLIPRED" or generic name "Prednisolone"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 23594-505 | MILLIPRED | PREDNISOLONE |
| 23594-510 | Millipred | PREDNISOLONE SODIUM PHOSPHATE |
| 73534-505 | MILLIPRED | PREDNISOLONE |
| 0527-5406 | PrednisoLONE | Prednisolone |
| 0603-1567 | PrednisoLONE | Prednisolone |
| 12634-686 | Prednisolone | Prednisolone |
| 21695-365 | Prednisolone | Prednisolone |
| 33261-475 | Prednisolone | Prednisolone |
| 50090-0655 | Prednisolone | Prednisolone |
| 50383-042 | Prednisolone | Prednisolone |
| 53217-193 | Prednisolone | Prednisolone |
| 58177-910 | Prednisolone | Prednisolone |
| 61919-291 | PREDNISOLONE | PREDNISOLONE |
| 63187-466 | Prednisolone | Prednisolone |
| 63629-1862 | Prednisolone | Prednisolone |
| 66116-603 | Prednisolone | Prednisolone |
| 67296-1656 | Prednisolone | Prednisolone |
| 68258-8987 | Prednisolone | Prednisolone |
| 68788-7207 | PrednisoLONE | Prednisolone |
| 68788-9096 | Prednisolone | Prednisolone |
| 70518-2084 | Prednisolone | Prednisolone |
| 0378-4710 | Prednisolone Sodium Phosphate | prednisolone |
| 0378-4715 | Prednisolone Sodium Phosphate | prednisolone |
| 0378-4730 | Prednisolone Sodium Phosphate | prednisolone |
Trademark Results [MILLIPRED]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 MILLIPRED 85711187 4327770 Live/Registered |
TRX PHARMACEUTICALS, LLC 2012-08-23 |
 MILLIPRED 77369190 not registered Dead/Abandoned |
Laser Pharmaceuticals, LLC 2008-01-11 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.